F950-0107 Screening compound: N-[3-(3-{3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-5-yl}-1,2,4-oxadiazol-5-yl)phenyl]acetamide

F950-0107 Screening compound: N-[3-(3-{3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-5-yl}-1,2,4-oxadiazol-5-yl)phenyl]acetamide
F950-0107 Screening compound: N-[3-(3-{3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-5-yl}-1,2,4-oxadiazol-5-yl)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F950-0107
N-[3-(3-{3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-5-yl}-1,2,4-oxadiazol-5-yl)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F950-0107

Molecular Formula

C22H17N5O2S (C22 H17 N5 O2 S)

Compound Name

N-[3-(3-{3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-5-yl}-1,2,4-oxadiazol-5-yl)phenyl]acetamide

IUPAC name

N-[3-(3-{3-methyl-1-phenyl-1H-thieno[23-c]pyrazol-5-yl}-124-oxadiazol-5-yl)phenyl]acetamide

SMILES

CC(Nc1cccc(-c2nc(-c3cc(c(C)nn4-c5ccccc5)c4s3)no2)c1)=O

InChI

InChI=1S/C22H17N5O2S/c1-13-18-12-19(30-22(18)27(25-13)17-9-4-3-5-10-17)20-24-21(29-26-20)15-7-6-8-16(11-15)23-14(2)28/h3-12H,1-2H3,(H,23,28)

InChI Key

ISYZYAZUPDSKSX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27205651

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

415.48

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.608

Distribution Coefficient, logD

4.608

Water Solubility, LogSw

-4.40

Polar Surface Area

69.681

Acid Dissociation Constant (pKa)

13.54

Base Dissociation Constant (pKb)

0.27

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

9.10

F950-0107 in Drug Discovery

Included in Screening Libraries

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F950-0107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F950-0107?
Check Price and Availability of F950-0107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F950-0107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F950-0107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F950-0107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F950-0107 available by request